Search for: "Bristol Meyers Squibb Company" Results 1 - 20 of 37
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
30 Jul 2004, 1:33 pm
Bristol-Meyers Squibb, the leading US AIDs drugs manufacturer, agreed Friday to settle for $300 million shareholder lawsuits alleging that the company inflated its sales by more than $2 billion from 1999 to 2001. [read post]
18 Aug 2021, 12:07 pm by jeffreynewmanadmin
 California Attorney General Rob Bonta today announced a $75 million nationwide settlement with global pharmaceutical company Bristol Myers Squibb (BMS), resolving allegations that BMS underpaid the drug rebates owed to Medi-Cal and other state Medicaid programs. [read post]
20 Jun 2020, 8:38 pm by Patent Docs
.; Eldora Ellison of Sterne, Kessler, Goldstein & Fox, PLLC; Serena Farquharson-Torres of Bristol-Meyers Squibb Company; and Joel Stern of the National Association of Minority and Women Owned Law Firms, Inc. will discuss the Practical Guide to D&I in the legal profession and reflect on how to improve diversity and inclusion. [read post]
21 Aug 2013, 9:05 am by Michael Lin
Also in Spring 2013, BDR Pharmaceuticals, Ltd. filed the 2nd Indian application for a CL (still pending) for Dasatinib, Bristol Meyers Squibb’s blockbuster anti-cancer drug. [read post]
19 Oct 2010, 8:06 am by Ben Vernia
., dismissed one set of codefendants (related to Bristol-Meyers Squibb, or BMS), but found the relator’s complaint against AstraZeneca to be sufficiently particular under Rule 9(b). [read post]
12 Apr 2016, 10:57 am by Dr. Shezad Malik
Nicholas Meyer recently filed against Bristol-Myers Squibb and Otsuka Pharmaceutical Co. in the U.S. [read post]
8 Mar 2016, 8:01 am by Dr. Shezad Malik
Nicholas Meyer recently filed against Bristol-Myers Squibb and Otsuka Pharmaceutical Co. in the U.S. [read post]
31 Jan 2015, 8:47 pm by Mark Summerfield
The issue of what, exactly, is ‘implicitly’ disclosed in a prior art reference arises in a decision of a full bench of the Federal Court issued on 23 January 2015 (Bristol-Myers Squibb Company v Apotex Pty Ltd [2015] FCAFC 2) in an appeal relating to a long-running dispute over the validity of a patent covering the antipsychotic drug aripiprazole. [read post]
7 Sep 2009, 12:06 pm
Eighteen months after the auction rate securities markets collapsed when Wall Street withdrew its support, companies like Bristol-Myers Squibb Co., Texas Instruments, Corning, and Teva Pharmaceuticals are still suffering from the Wall Street debacle. [read post]
4 Aug 2016, 9:24 am by Neumann Law Group
It is Bristol-Myers Squibb’s top-selling drug; it earned the pharmaceutical company $6.4 billion in 2013. [read post]
16 Sep 2011, 11:02 am by eithurburn@getnicklaw.com
  The state has already settled cases with Astra Zeneca, Abbott Laboratories, GlaxoSmithKline, Amgen Inc., Baxter Healthcare Corp., Boehringer Ingelhelm Roxane, and Dey Pharmaceutical and has prevailed at trial against Johnson & Johnson and Bristol-Meyers Squibb. [read post]
” Here, the State of West Virginia, by its Attorney General alleged that the defendants Bristol-Meyers Squibb Company, Sanofi-Aventis U.S., LLC, Sanofi U.S. [read post]
9 Mar 2011, 11:14 am by PaulKostro
Bristol-Meyers Squibb Co., 156 N.J. 455, 463 (1998) (quoting N.J.R.E. 803(b)(4)). [read post]
9 May 2021, 8:09 am by Throneberry Law Group
Other defendants named in the case included Bristol-Meyers Squibb, Cyprus Amax Minerals Company, and Whittaker Clark & Daniels. [read post]
29 Jul 2013, 10:05 am
  Also in Spring 2013, BDR Pharmaceuticals, Ltd applied for a CL for Bristol Meyers Squibb’s anti-cancer drug Dasatinib. [read post]
25 Jun 2017, 10:42 pm by Barry Barnett
Bristol-Meyers Squibb Co. v. [read post]
20 Jan 2016, 8:00 am by Robert Kreisman
Another expensive drug, this one produced by Bristol-Meyers Squibb, is the hepatitis C pill, Daklinza, which costs $63,000 for a 12-week supply. [read post]